Clinica Chimica Acta 1999 - 2000: Vol 290 Index

5 Pages·1.2 MB·English

ELSEVIEGRis
Clinica Chimica Acta 290 (2000) 227-228
www.elsevier.com/locate/clinchim
Author index
Volume 290 (2000)
Adachi, T., Wang, J., Wang, X.L., Age-related Hashimoto, Y., see Ono, K. 290, 159
change of plasma extracellular-superoxide dis- Higa, T.E., see Fagg, K.L. 290, 73
mutase 290, 169 Hirata, K., see Yajima, T. 290, 117
Arakawa, Y., see Ono, K. 290, 159 Hjelm Poulsen, J., see Ehrnrooth, E. 290, 129
Arenas, J., see Navarro-Gonzalvez, J.A. 290, 221 Hornung, N., see Ehrnrooth, E. 290, 129
Hurtado, J., see Motellon, J.L. 290, 189
Barnes, I.C., see Price, C.P. 290, 5
Bissell, M.G., see Petersen, J.R. 290, 213 las, J., Miuhl, A., Stodckler-Ipsiroglu, S.,
Bota, A., Gella, F.-J., Canalias, F., Optimization of Guanidinoacetate methyltransferase (GAMT)
adenosine deaminase assay by response surface deficiency: non-invasive enzymatic diagnosis of
methodology 290, 145 a newly recognized inborn error of metabolism
290, 179
Canalias, F., see Bota, A. 290, 145
Iwasaki, A., see Ono, K. 290, 159
Cembrowski, G.S., see Fagg, K.L. 290, 73
Jaras, M.J., see Motelldén, J.L. 290, 189
de Miguel, F., see Motellon, J.L. 290, 189
Jiménez, F.J., see Motellon, J.L. 290, 189
Diaz, A., see Motellon, J.L. 290, 189
Kameshima, H., see Yajima, T. 290, 117
Ehrnrooth, E., Sgrensen, B.S., Meldgaard, P., Hor-
Kinniburgh, D.W., see Fagg, K.L. 290, 73
nung, N., Hjelm Poulsen, J., Von der Maase, H.,
Kobayashi, D., see Yajima, T. 290, 117
A new quantitative RT-PCR assay for thymidyl-
Kurokawa, K., see Ono, K. 290, 159
ate synthase mRNA in blood leukocytes applied
to cancer patients and healthy controls 290,
Linde, M.K., see Petersen, J.R. 290, 213
129
Lobato, R.D., see Navarro-Gonzalvez, J.A. 290,
Esbrit, P., see Motellon, J.L. 290, 189
221
Estey, C.A., see Mifflin, T.E. 290, 199
McGann, J.T., see Fagg, K.L. 290, 73
Fagg, K.L., Gordon, P., Reib, B., McGann, J.T.,
Higa, T.E., Kinniburgh, D.W., Cembrowski, Meldgaard, P., see Ehrnrooth, E. 290, 129
G.S., Laboratory restructuring in metropolitan Mifflin, T.E., Estey, C.A., Felder, R.A., Robotic
Edmonton: a model for laboratory reorganization automation performs a nested RT-PCR analysis
in Canada 290, 73 for HCV without introducing sample contamina-
Felder, R.A., see Mifflin, T.E. 290, 199 tion 290, 199
Furuya, D., see Yajima, T. 290, 117 Motellon, J.L., Jiménez, F.J., de Miguel, F., Jaras,
M.J., Diaz, A., Hurtado, J., Esbrit, P., Para-
Gella, F.-J., see Bota, A. 290, 145 thyroid hormone-related protein, parathyroid
Gomez, P., see Navarro-Gonzalvez, J.A. 290, 221 hormone, and vitamin D in hypercalcemia of
Gordon, P., see Fagg, K.L. 290, 73 malignancy 290, 189
PII: S0009-8981(99)00232-6
228 Author index vol. 290 (2000)
Miihl, A., see Ilas, J. 290, 179 Richardson, H., Laboratory medicine in Ontario: its
Miiller, M.M., see Oppolzer, E.M. 290, 37 downsizing and the consequences on quality
Murata, Y., see Ono, K. 290, 159 290, 57
Rodriguez-Arias, C.A., see Navarro-Gonzalvez,
Navarro-Gonzalvez, J.A., Arenas, J., Lobato, R.D., J.A. 290, 221
Gomez, P., Rodriguez-Arias, C.A., Levels of
nitric oxide are markedly increased in cere- Saito, E., see Ono, K. 290, 159
brospinal fluid from patients with severe head Sawada, T., see Ono, K. 290, 159
injury 290, 221 S¢rensen, B.S., see Ehrnrooth, E. 290, 129
Stockler-Ipsiroglu, S., see Ilas, J. 290, 179
Okuda, K., see Tatsumi, N. 290, 93
Ono, K., Sawada, T., Murata, Y., Saito, E., Iwasaki, Tatsumi, N., Okuda, K., Tsuda, I., A new direction
A., Arakawa, Y., Kurokawa, K., Hashimoto, Y., in automated laboratory testing in Japan: five
Pentagalloylglucose, an antisecretory component years of experience with total laboratory automa-
of Paeoniae radix, inhibits gastric H”, K’- tion system management 290, 93
ATPase 290, 159 Tsuda, I., see Tatsumi, N. 290, 93
Oppolzer, E.M., Miller, M.M., Health care system
and laboratory medicine in Austria: present von der Maase, H., see Ehrnrooth, E. 290, 129
status and future perspectives 290, 37
Wang, J., see Adachi, T. 290, 169
Petersen, J.R., Linde, M.K., Bissell, M.G., The Wang, X.L., see Adachi, T. 290, 169
possible association of decreased total choles- Watanabe, N., see Yajima, T. 290, 117
terol and severity of disease in elderly hospital-
ized patients 290, 213 Yagihashi, A., see Yajima, T. 290, 117
Price, C.P., Barnes, I.C., Laboratory medicine in the Yajima, T., Yagihashi, A., Kameshima, H., Furuya,
United Kingdom: 1948-1998 and beyond 290, D., Kobayashi, D., Hirata, K., Watanabe, N.,
5 Establishment of quantitative reverse transcrip-
tion—polymerase chain reaction assays for
Reib, B., see Fagg, K.L. 290, 73 human telomerase-associated genes 290, 117
Clinica Chimica Acta 290 (2000) 229-231
www.elsevier.com/locate/clinchim
Subject index
Volume 290 (2000)
1.25(OH),D,; PTHrP; PTH; Hypercalcemia of Core laboratory; Integrated laboratory system;
malignancy 290, 189 DRG/PPS system; Managed care; POC tests;
Laboratory efficiency 290, 93
Acid secretion; Paeoniae radix; Pentagalloylglu-
cose; H*; K*-ATPase 290, 159 Creatine deficiency; Guanidinoacetate; Fibro-
blasts; Lymphoblasts; Amniotic cells 290, 179
Adenosine deaminase isoenzymes; Response sur-
face methodology; Pleural fluid. 290, 145 DRG/PPS system; Integrated laboratory system;
Managed care; Core laboratory; POC tests; Lab-
Amniotic cells; Creatine deficiency; Guanidinoace- oratory efficiency 290, 93
tate; Fibroblasts; Lymphoblasts 290, 179
European health care; Austrian health politics;
Antioxidant capacity; Extracellular-superoxide
Hospital management strategies 290, 37
dismutase; Plasma 290, 169
Extracellular-superoxide dismutase; Plasma;
Austrian health politics; European health care;
Antioxidant capacity 290, 169
Hospital management strategies 290, 37
Fibroblasts; Creatine deficiency; Guanidinoacetate;
Automation; Robot; RT-PCR; Hepatitis C; HCV;
Lymphoblasts; Amniotic cells 290, 179
Molecular diagnostics; Contamination 290, 199
Guanidinoacetate; Creatine deficiency; Fibro-
Cholesterol; Low cholesterol; Severity of disease;
blasts; Lymphoblasts; Amniotic cells 290, 179
Outcome study 290, 213
HCV; Automation; Robot; RT-PCR; Hepatitis C;
Clinical Biochemists; Laboratory medicine restruc-
Molecular diagnostics; Contamination 290, 199
turing; Health-care restructuring; Health-care
expenditure; Laboratory Physicians; Medical bio-
chemistry; Quality improvement 290, 57 Health-care expenditure; Laboratory medicine
restructuring; Health-care restructuring; Labora-
Colorectal cancer; Quantitative RT—PCR; Internal tory Physicians; Medical biochemistry; Clinical
standard; Thymidylate synthase mRNA; TS ac- Biochemists; Quality improvement 290, 57
tivity; Leukocytes 290, 129
Health-care restructuring; Laboratory medicine
Contamination; Automation; Robot; RT-PCR; restructuring; Health-care expenditure; Labora-
Hepatitis C; HCV; Molecular diagnostics 290, tory Physicians; Medical biochemistry; Clinical
199 Biochemists; Quality improvement 290, 57
PII: S0009-8981(99)00233-8
230 Subject index vol. 290 (2000)
Hepatitis C; Automation; Robot; RT-PCR; HCV; Molecular diagnostics; Automation; Robot; RT-
Molecular diagnostics; Contamination 290, 199 PCR; Hepatitis C; HCV; Contamination 290,
199
Hospital management strategies; European health
care; Austrian health politics 290, 37 Outcome study; Cholesterol; Low cholesterol;
Severity of disease 290, 213
Hypercalcemia of malignancy; PTHrP; PTH;
1.25(O0H),D, 290, 189 Paeoniae radix; Pentagalloylglucose; H*; K*-AT-
Pase; Acid secretion 290, 159
H*; Paeoniae radix; Pentagalloylglucose; K*-AT-
Pase; Acid secretion 290, 159
POC tests; Integrated laboratory system; DRG/
PPS system; Managed care; Core laboratory;
Integrated laboratory system; DRG/PPS system;
Laboratory efficiency 290, 93
Managed care; Core laboratory; POC tests; Lab-
oratory efficiency 290, 93
PTHrP; PTH; 1.25(OH),D,; Hypercalcemia of
malignancy 290, 189
Internal standard; Quantitative RT-PCR; Thy-
midylate synthase mRNA; TS activity;
Leukocytes; Colorectal cancer 290, 129 PTH; PTHrP; 1.25(OH),D,; Hypercalcemia of
malignancy 290, 189
K*-ATPase; Paeoniae radix; Pentagalloylglucose;
H”™; Acid secretion 290, 159
Pentagalloylglucose; Paeoniae radix; H*; K*-AT-
Pase; Acid secretion 290, 159
Laboratory Physicians; Laboratory medicine re-
structuring; Health-care restructuring; Health-
Plasma; Extracellular-superoxide dismutase; Anti-
care expenditure; Medical biochemistry; Clinical
oxidant capacity 290, 169
Biochemists; Quality improvement 290, 57
Laboratory efficiency; Integrated laboratory sys- Pleural fluid; Response surface methodology;
tem; DRG/PPS system; Managed care; Core Adenosine deaminase isoenzymes 290, 145
laboratory; POC tests 290, 93
Quality improvement; Laboratory medicine re-
Laboratory medicine restructuring; Health-care structuring; Health-care restructuring; Health-
restructuring; Health-care expenditure; Labora- care expenditure; Laboratory Physicians; Medi-
tory Physicians; Medical biochemistry; Clinical cal biochemistry; Clinical Biochemists 290, 57
Biochemists; Quality improvement 290, 57
Quantitative RT-PCR; Internal standard; Thy-
Leukocytes; Quantitative RT-PCR; Internal stan-
midylate synthase mRNA; TS activity;
dard; Thymidylate synthase mRNA; TS activity;
Leukocytes; Colorectal cancer 290, 129
Colorectal cancer 290, 129
mRNA; hTERT; TEP1; RT—PCR; Telomerase;
Low cholesterol; Cholesterol; Severity of disease;
TaqMan™ PCR 290, 117
Outcome study 290, 213
Lymphoblasts; Creatine deficiency; Guanidinoace- RT-PCR; hTERT; TEP1; mRNA; Telomerase;
TaqMan™ PCR 290, 117
tate; Fibroblasts; Amniotic cells 290, 179
Managed care; Integrated laboratory system; RT-PCR; Automation; Robot; Hepatitis C; HCV;
Molecular diagnostics; Contamination 290, 199
DRG/PPS system; Core laboratory; POC tests;
Laboratory efficiency 290, 93
Response surface methodology; Adenosine
Medical biochemistry; Laboratory medicine re- deaminase isoenzymes; Pleural fluid. 290, 145
structuring; Health-care restructuring; Health-
care expenditure; Laboratory Physicians; Clinical Robot; Automation; RT-PCR; Hepatitis C; HCV;
Biochemists; Quality improvement 290, 57 Molecular diagnostics; Contamination 290, 199
Subject index vol. 290 (2000) 231
Severity of disease; Cholesterol; Low cholesterol; TaqMan™ PCR; hTERT; TEP1; mRNA; RT-
Outcome study 290, 213 PCR; Telomerase 290, 117
TEP1; hTERT; mRNA; RT-PCR; Telomerase; Telomerase; hTERT; TEP1; mRNA; RT-PCR;
TaqMan™ PCR 290, 117 TaqMan’ PCR 290, 117
hTERT; TEP1; mRNA; RT-PCR; Telomerase; Thymidylate synthase mRNA; Quantitative RT-
TaqMan™ PCR 290, 117 PCR; Internal standard; TS activity; Leukocytes;
Colorectal cancer 290, 129
TS activity; Quantitative RT—PCR; Internal stan-
dard; Thymidylate synthase mRNA; Leukocytes;
Colorectal cancer 290, 129